260 related articles for article (PubMed ID: 17323312)
21. [Clinical studies in rehabilitation research--problems and solutions from biometrical perspective].
Muche R; Rösch M; Flierl S; Gaus W
Rehabilitation (Stuttg); 2000 Aug; 39(4):200-4. PubMed ID: 11008277
[TBL] [Abstract][Full Text] [Related]
22. Simultaneously optimizing dose and schedule of a new cytotoxic agent.
Braun TM; Thall PF; Nguyen H; de Lima M
Clin Trials; 2007; 4(2):113-24. PubMed ID: 17456511
[TBL] [Abstract][Full Text] [Related]
23. A note on the power of Fisher's least significant difference procedure.
Meier U
Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
[TBL] [Abstract][Full Text] [Related]
24. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
Schwartz TA; Denne JS
Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
[TBL] [Abstract][Full Text] [Related]
25. Choice of delta noninferiority margin and dependency of the noninferiority trials.
Tsong Y; Zhang J; Levenson M
J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
27. Covariate-adjusted response-adaptive designs for binary response.
Rosenberger WF; Vidyashankar AN; Agarwal DK
J Biopharm Stat; 2001 Nov; 11(4):227-36. PubMed ID: 12018777
[TBL] [Abstract][Full Text] [Related]
28. A three-outcome design for randomized comparative phase II clinical trials.
Hong S; Wang Y
Stat Med; 2007 Aug; 26(19):3525-34. PubMed ID: 17262879
[TBL] [Abstract][Full Text] [Related]
29. A group-sequential design for clinical trials with treatment selection.
Stallard N; Friede T
Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
[TBL] [Abstract][Full Text] [Related]
30. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
Tsong Y; Wang SJ; Hung HM; Cui L
J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
[TBL] [Abstract][Full Text] [Related]
31. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
32. Improving efficiency of ALS clinical trials using lead-in designs.
Moore DH; Miller RG
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
[TBL] [Abstract][Full Text] [Related]
33. An efficient design for a study comparing two drugs, their combination and placebo.
Wei L
Stat Med; 2006 Jun; 25(12):2043-58. PubMed ID: 16220485
[TBL] [Abstract][Full Text] [Related]
34. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
Mielke M; Munk A; Schacht A
Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
[TBL] [Abstract][Full Text] [Related]
35. Multi-arm clinical trials of new agents: some design considerations.
Freidlin B; Korn EL; Gray R; Martin A
Clin Cancer Res; 2008 Jul; 14(14):4368-71. PubMed ID: 18628449
[TBL] [Abstract][Full Text] [Related]
36. Sample size determination in step-up testing procedures for multiple comparisons with a control.
Kwong KS; Cheung SH; Wen MJ
Stat Med; 2010 Nov; 29(26):2743-56. PubMed ID: 20799258
[TBL] [Abstract][Full Text] [Related]
37. Partition testing in dose-response studies with multiple endpoints.
Liu Y; Hsu J; Ruberg S
Pharm Stat; 2007; 6(3):181-92. PubMed ID: 17654696
[TBL] [Abstract][Full Text] [Related]
38. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
Sankoh AJ
Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
[TBL] [Abstract][Full Text] [Related]
39. A comparison of group sequential methods for binary longitudinal data.
Spiessens B; Lesaffre E; Verbeke G
Stat Med; 2003 Feb; 22(4):501-15. PubMed ID: 12590410
[TBL] [Abstract][Full Text] [Related]
40. Adaptive randomization for multiarm comparative clinical trials based on joint efficacy/toxicity outcomes.
Ji Y; Bekele BN
Biometrics; 2009 Sep; 65(3):876-84. PubMed ID: 19173694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
